Biologics
-
Biologics
Orthofix Launches Magnesium-Based Settable Bone Void Filler
Opus Mg Set provides a procedure-specific solution for orthopedic fracture care and trauma applications.Business Wire 09.21.21
-
Biologics
Anika's Tactoset Nabs Additional FDA OK for Hardware Augmentation
Expands capability of Tactoset injectable bone subsititute for augmenting suture anchor fixation.GlobeNewswire 09.14.21
-
Biologics
Fuse Medical Rolls Out FuseChoice Dermal Matrix
Preserves the inherent properties of collagen and elastin.Business Wire 09.09.21
-
Biologics
Bioventus Takes First Step in CartiHeal Acquisition
Company makes $50 million escrow payment.Globe Newswire 08.30.21
-
Biologics
Orthofix Launches New fiberFUSE Strip
First patients implanted with the advanced fiber bone-graft solution containing cancellous bone.Business Wire 07.28.21
-
Biologics
RTI Surgical Enters Strategic Agreement with Exactech
Acquires Exactech's Optecure, a 510(k)-cleared demineralized bone matrix for use as a bone graft extender.RTI Surgical 07.13.21
-
Biologics
Bioventus Rolls Out OsteoAmp Select Flowable in U.S.
Flowable allograft bone graft substitute for lumbar spine fusion, cervical spine fusion, foot & ankle fusion.GlobeNewswire 07.13.21
-
Biologics
Celularity, Arthrex Forge Supply and Distribution Deal
Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine.Globe Newswire 07.02.21
-
Biologics
MIMEDX’s EPIFIX Gains Japanese Regulatory Approval
Availability of EPIFIX allografts is expected early 2022.Globe Newswire 06.08.21
-
Biologics
FDA OKs Elute's Antibiotic Eluting Bone Void Filler Trial
Will evaluate EP Granules with Tobramycin in difficult-to-treat bone infections.Sam Brusco, Associate Editor 06.08.21
-
Biologics
Aziyo Biologics Recalls One Lot of FiberCel Fiber Viable Bone Matrix
Some patients that tested positive for tuberculosis after treatment.Michael Barbella, Managing Editor 06.07.21
-
Biologics
Paragon 28 Adds Three Families of DBM to its Biologics Portfolio
Company now offers BEAST Injectable, BEAST PLUS, and BEAST Osteobiologic Sponge for bone grafting applications in the foot and ankle.Michael Barbella, Managing Editor 05.21.21
-
Biologics
Clinical Data Show High Fusion Rates With ProteiOS Growth Factor
Biologica Technologies' allograft-derived growth factor leads to fusion rates that are higher or comparable to those in other published studies.Michael Barbella, Managing Editor 05.18.21
-
Biologics
Biogennix Rolls Out Agilon Strip Bone Graft
Agilon Strip maximizes direct contact with bone when implanted.Sam Brusco, Associate Editor 04.14.21
-
Biologics | Large Joint
Bioventus Begins Trial of MOTYS (PTP-001) to Treat Knee OA
MOTYS is a placental tissue particulate comprised of amnion, chorion, and umbilical cord tissue.Sam Brusco, Associate Editor 03.15.21
-
Biologics
Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
MPO's Sean Fenske speaks with Mike Daley of OrthogenRx about the role HA plays in alleviating knee pain and the challenges with the FDA over it.Sean Fenske, Editor-in-Chief 03.02.21
-
Biologics
Paragon 28 Launches MgNum Bone Void Filler
Expands its biologics portfolio.Charles Sternberg, Assistant Editor 02.22.21
-
Biologics
Washington University Professor Honored for Functional Cartilage Engineering Research
Scholar's research is soon expected to begin a Phase I clinical trial.Michael Barbella, Managing Editor 02.22.21
-
Biologics
Ranfac, Endocellutions Form Cervos Medical
Cervos Medical represents a joint venture to bring next generation surgical and orthobiologic devices to the market.Sean Fenske, Editor-in-Chief 02.19.21
-
Biologics
The FDA’s Flip-Flop on Hyaluronic Acid
Offering an introduction to this treatment modality for osteoarthritis, this article also looks at recent changes at FDA.Online Exclusives Mike Daley, CEO, OrthogenRx 02.10.21
